Annovis Cost Of Revenue from 2010 to 2025

ANVS Stock  USD 1.83  0.04  2.23%   
Annovis Bio Cost Of Revenue yearly trend continues to be comparatively stable with very little volatility. Cost Of Revenue will likely drop to 9,791 in 2025. From the period from 2010 to 2025, Annovis Bio Cost Of Revenue quarterly data regression had r-value of  0.45 and coefficient of variation of  30.67. View All Fundamentals
 
Cost Of Revenue  
First Reported
2012-12-31
Previous Quarter
8.3 M
Current Value
13.8 M
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 7.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.
  
Check out the analysis of Annovis Bio Correlation against competitors.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Annovis Bio over the last few years. Cost of Revenue is found on Annovis Bio income statement and represents the costs associated with goods and services Annovis Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Annovis Bio's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Annovis Cost Of Revenue Regression Statistics

Arithmetic Mean10,181
Geometric Mean0.00
Coefficient Of Variation30.67
Mean Deviation1,922
Median11,452
Standard Deviation3,123
Sample Variance9.8M
Range11.5K
R-Value0.45
Mean Square Error8.3M
R-Squared0.20
Significance0.08
Slope294.44
Total Sum of Squares146.3M

Annovis Cost Of Revenue History

2025 9791.46
202410.3 K
201211.5 K
2011null
2010 5376.0

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue10.3 K9.8 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.